Literature DB >> 8227058

Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene.

M J Low1, B Liu, G D Hammer, M Rubinstein, R G Allen.   

Abstract

Mice harboring a transgene composed of proopiomelanocortin (POMC) gene promoter sequences (nucleotides -706 to +64) ligated to the simian virus (SV) 40 early gene encoding large T antigen developed large POMC-expressing pituitary tumors. Histologically the tumors arose from the intermediate lobe, contained nuclear SV40 T antigen and POMC peptides, but did not express other pituitary hormones. POMC processing in the pituitary tumors was indistinguishable from normal mouse intermediate lobe melanotrophs and was characterized by high proportions of acetylated and carboxyl-terminal shortened beta-endorphins, and amino-terminal acetylated alpha-melanocyte-stimulating hormone, and virtually no adrenocorticotropic hormone (ACTH)(1-39), beta-lipotropin, or POMC. The tumors contained abundant levels of mRNA for the prohormone convertase PC2 and undetectable levels of PC1. Normal mouse neurointermediate lobe also has a high ratio of PC2/PC1 expression that is distinct from the relative abundance of PC1 in anterior lobe and AtT-20 corticotroph cells. In contrast, extracts from tumors transplanted subcutaneously in nude mice contained predominantly nonacetylated forms of beta-endorphin(1-31) and -(1-27), very little ACTH(1-39), almost no corticotropin-like intermediate peptide or alpha-melanocyte-stimulating hormone, and higher proportions of intact POMC. Surprisingly, despite the less efficient proteolytic cleavage, a transplanted tumor expressed both PC1 and PC2. These studies are the first biochemical documentation of a melanotroph pituitary tumor in a rodent species and provide a new model for the investigation of pituitary oncogenesis and the molecular basis of tissue-specific prohormone post-translational processing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227058

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland.

Authors:  Eros Lazzerini Denchi; Claire Attwooll; Diego Pasini; Kristian Helin
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  The changes of pro-opiomelanocortin neurons in type 2 diabetes mellitus rats after ileal transposition: the role of POMC neurons.

Authors:  Weijie Chen; Zhibo Yan; Shaozhuang Liu; Guangyong Zhang; Dong Sun; Sanyuan Hu
Journal:  J Gastrointest Surg       Date:  2011-06-30       Impact factor: 3.452

Review 3.  Molecular basis of pituitary oncogenesis.

Authors:  M Tada; H Kobayashi; T Moriuchi
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model.

Authors:  Shey-Cherng Tzou; Isabella Lupi; Melissa Landek; Angelika Gutenberg; Ywh-Min Tzou; Hiroaki Kimura; Giovanni Pinna; Noel R Rose; Patrizio Caturegli
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

5.  DNA elements with AT-rich core sequences direct pituitary cell-specific expression of the pro-opiomelanocortin gene in transgenic mice.

Authors:  B Liu; M Mortrud; M J Low
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

6.  Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis.

Authors:  M Rubinstein; J S Mogil; M Japón; E C Chan; R G Allen; M J Low
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

7.  Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.

Authors:  S Akita; J Webster; S G Ren; H Takino; J Said; O Zand; S Melmed
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

Review 8.  Genetically engineered mouse models of pituitary tumors.

Authors:  David A Cano; Alfonso Soto-Moreno; Alfonso Leal-Cerro
Journal:  Front Oncol       Date:  2014-08-01       Impact factor: 6.244

9.  EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis.

Authors:  Takako Araki; Xiaohai Liu; Hiraku Kameda; Yukiko Tone; Hidenori Fukuoka; Masahide Tone; Shlomo Melmed
Journal:  J Endocr Soc       Date:  2017-01-20

Review 10.  Animal models of pituitary neoplasia.

Authors:  K E Lines; M Stevenson; R V Thakker
Journal:  Mol Cell Endocrinol       Date:  2015-08-28       Impact factor: 4.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.